US Starts Section 301 Probe of Germany Over Pharmaceuticals
The US has begun a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.
By Derek Wallbank, Rachel Cohrs Zhang · Bloomberg Markets
The US has begun a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.